After Years of Captivity by Big Pharma, the FDA Will Finally Test Whether Administering Multiple "Vaccines" At Once Is Actually Safe

The FDA just didn't have the resources to do tests to insure the safety of children. The government was too busy spending millions to determine if drag queens can reduce their stress levels through flamenco dancing lessons. A much much important question, I'm sure you agree.

This study seems to about adults getting multiple respiratory virus vaccines at once, but the study will presumably yield clues about whether injecting kids with 40-70 vaccines is dangerous.

Trump and his FDA will finally spend money and time to ask the minor question: Are we literally harming our children just to pad Big Pharma's profits?

Citing a "new evidenced based philosophy," the FDA's Center for Biologics Evaluation and Research (CBER) is preparing to take a hard line against the common practice of administering certain respiratory virus vaccines at the same time.

The leadership at CBER--which oversees vaccines and other biologic products like cell and gene therapies at the FDA--will now require randomized, controlled trials in people eligible for multiple vaccines before drugmakers can promote coadministration of the shots or "some sequence of the vaccines," CBER Director Vinay Prasad, M.D., wrote in a memo posted on the FDA's website.

...

Apparently reading the writing on the wall, Pfizer last month sent a letter to healthcare providers warning that certain lots of its 2025-26 COVID vaccine "contain unapproved prescribing information inside the cartons."

That language related to "concomitant administration of Pfizer-BioNTech COVID-19 vaccine, bivalent with a respiratory syncytial virus (RSV) vaccine or with an RSV vaccine and an influenza vaccine in individuals 65 years of age and older," according to the letter, which the FDA has posted on its Comirnaty information page.

Pfizer did not provide a statement in response to Prasad's communications, though a company spokesperson directed Fierce toward its physician letter on the FDA's website.

In the memo, CBER's Prasad took issue with the fact that past company claims about concomitant vaccine administration were "made on the basis of small randomized studies showing non-inferior antibody titers." But the CBER is "unsure" whether those titers correspond to clinical protection and holds concerns that "such small trials are inherently incapable of adequately documenting safety signals," according to Prasad.

"The studies are simply too small to identify potential increases in adverse events, which Americans may wish to know," he wrote.

The Biden administration supported vaccine coadministration as a means to increase immunization rates, though Prasad has frequently criticized the practice, The Washington Post reported this week.

Who knows -- NASA might soon be spending money on actual space research instead of studying whether trannys experience any particular ill-effects in zero G.

posted by Ace at 02:28 PM

| Access Comments